Drug interaction study of birth control pill in postmenopausal women
Part of Infections clinical trials.
This study tests how a birth control pill interacts with another drug (ganfeborole) in healthy postmenopausal women. It aims to see if taking them together changes the levels of the birth control hormones in your body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a female who is not able to become pregnant (postmenopausal).
- You must be between 18 and 64 years old.
- You must be in good health.
- You must have adequate kidney and liver function.
- You cannot have taken certain medications, vaccines, or alcohol within the required time before the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental oral TB drug called alpibectir given together with ethionamide for people with newly diagnosed lung TB. The goal is to see how well the combination works and if it is safe.
This study looks at how genes affect the way the body processes birth control pills. You take a low-dose pill for one cycle and have blood draws to measure hormone levels.
This study tests a new combination birth control pill to see how it affects blood vessel and heart health in women aged 18–49. Researchers want to understand if this pill is safe and effective compared to standard options.
This study tests how two different tablet versions of the study drug BGB-58067 enter the body and how food affects the drug. Healthy volunteers take the drug to help understand the best way to give it in future trials.
This study looks at how tuberculosis medications interact with each other or with other drugs you may be taking. The goal is to make sure your treatment is as safe and effective as possible.
This study tests how a new experimental drug (BGB-58067) moves through your body and how two common medications affect that process. Researchers need healthy volunteers to understand if these drug interactions are safe.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.